Statistical methods in psychiatry & mental health trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
ANCOVA
Mixed-effects model
MMRM (mixed model for repeated measures)
Multiple imputation / missing data
Cochran-Mantel-Haenszel test
Odds ratio
t-test
Logistic regression
All psychiatry & mental health trials
833 results
- PATHIndependent statistical analysis of PATH Partnering to Achieve Tobacco-free Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01533974).
- PATH-MCIIndependent statistical analysis of Problem Adaptation Therapy for Mild Cognitive Impairment and Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03043573).
- PATHFINDERIIIndependent statistical analysis of Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Patient Satisfaction Study: Clean Intermittent Self-Catheterization Teaching: Complete Statistical AnalysisIndependent statistical analysis of Patient Satisfaction Study: Clean Intermittent Self-Catheterization Teaching: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678444).
- PDC-1421 Treatment in Adult Patients With ADHD: Complete Statistical AnalysisIndependent statistical analysis of PDC-1421 Treatment in Adult Patients With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05202327).
- Peer Based Suicide Prevention: Complete Statistical AnalysisIndependent statistical analysis of Peer Based Suicide Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04222673).
- Peer to Peer Delivery of Behavioral Activation: Complete Statistical AnalysisIndependent statistical analysis of Peer to Peer Delivery of Behavioral Activation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02292849).
- Penn State TXT2Quit Study: Complete Statistical AnalysisIndependent statistical analysis of Penn State TXT2Quit Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02367391).
- Penn State TXT2STAYQUIT Study- a Texting Study to Help Hospitalized Smokers Stay Quit: Complete Statistical AnalysisIndependent statistical analysis of Penn State TXT2STAYQUIT Study- a Texting Study to Help Hospitalized Smokers Stay Quit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PERSISTIndependent statistical analysis of Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01358357).
- PersistIndependent statistical analysis of Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04433975).
- Personalized Feedback for Distress Intolerant Smokers: Complete Statistical AnalysisIndependent statistical analysis of Personalized Feedback for Distress Intolerant Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03918031).
- Personalized Therapeutic Neuromodulation for Anhedonic Depression: Complete Statistical AnalysisIndependent statistical analysis of Personalized Therapeutic Neuromodulation for Anhedonic Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05144789).
- PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects: Complete Statistical AnalysisIndependent statistical analysis of PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PET-CRAIndependent statistical analysis of Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00376558).
- Pharmacist Intervention to Improve Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Pharmacist Intervention to Improve Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06943287).
- Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02884908).
- Pharmacogenetics of Alcohol: Treatment Implications: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenetics of Alcohol: Treatment Implications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00734656).
- Pharmacogenetics of Nicotine Addiction Treatment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenetics of Nicotine Addiction Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01314001).
- Pharmacogenomic Testing in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenomic Testing in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03270891).
- Pharmacokinetic and Subjective Effects of Heated Tobacco Products: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic and Subjective Effects of Heated Tobacco Products: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06356610).
- Pharmacokinetic Study of 4 mg Nicotine Lozenge.: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of 4 mg Nicotine Lozenge.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669122).
- Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine: Complete Statistical AnalysisIndependent statistical analysis of Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04711005).
- Phase I Study: Stop Smoking Therapy for Ontario Patients (STOP): Complete Statistical AnalysisIndependent statistical analysis of Phase I Study: Stop Smoking Therapy for Ontario Patients (STOP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00356993).
- PHASE ProjectIndependent statistical analysis of Premenstrual Hormonal and Affective State Evaluation (PHASE) Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03862469).
- Phenobarbital for Acute Alcohol Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Phenobarbital for Acute Alcohol Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01184417).
- PHOTOIndependent statistical analysis of Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pilot Study Comparing the Effectiveness of Two Different Methods of Acoustic Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Pilot Study Comparing the Effectiveness of Two Different Methods of Acoustic Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pilot Study of Duloxetine in Psychological Resilience: Complete Statistical AnalysisIndependent statistical analysis of Pilot Study of Duloxetine in Psychological Resilience: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00331799).
- Pilot Study of Patient Navigation to Promote Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Pilot Study of Patient Navigation to Promote Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01414036).
- Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders: Complete Statistical AnalysisIndependent statistical analysis of Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse: Complete Statistical AnalysisIndependent statistical analysis of Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pilot Study: Preoperative Nicotine Lozenges: Complete Statistical AnalysisIndependent statistical analysis of Pilot Study: Preoperative Nicotine Lozenges: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00586482).
- Pioglitazone for the Treatment of Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone for the Treatment of Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01717040).
- PITCH-EIndependent statistical analysis of Pain Inflammation and Cannabis in HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05554146).
- Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.: Complete Statistical AnalysisIndependent statistical analysis of Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PLUSIndependent statistical analysis of Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- POEMIndependent statistical analysis of POEM (Practice Of Embracing Each Moment) STUDY: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03078608).
- PoNDIndependent statistical analysis of Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels: Complete Statistical AnalysisIndependent statistical analysis of Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries: Complete Statistical AnalysisIndependent statistical analysis of Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03470675).
- Poststroke Depression in Hemorrhagic Stroke: Complete Statistical AnalysisIndependent statistical analysis of Poststroke Depression in Hemorrhagic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03826875).
- PPARγ Agonist Treatment for Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of PPARγ Agonist Treatment for Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02774343).
- PPAUIndependent statistical analysis of Feasibility and Effectiveness of a Specialized Brief Intervention for Hazardous Drinkers in an Emergency Department.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PPJIndependent statistical analysis of Piloting "Positive Peer Journaling" a Journaling Practice to Support Recovery From Addiction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…